Skip to main content
. 2009 May 28;10:31. doi: 10.1186/1471-2172-10-31

Table 1.

Baseline data for all the recruited subjects screened with T-SPOT.TB assay and TST

HIV+ATB HIV+LTB HIV only
Patient No. 32 46 22
Age (years)
median (SD)
37.0 (8.6) 33.9 (6.7) 33.7 (5.8)
Male/Female 22/10 26/22 9/13
BCG vaccination history Yes Yes Yes
CD4+ T cell counts, n (%)
 <200/μl 21 (65.6) 4 (8.7) 5 (22.7)
 200–500/μl 10 (31.3) 19 (41.3) 9 (40.9)
 >500/μl 1 (3.1) 23 (50.0) 8 (36.4)
Anti-TB treatment, n (%)
 <1 mo 18 (56.3) No No
 1–3 mo 9 (28.1)
 >3 mo 5 (15.6)
HAART, n (%) 20 (62.5) 4 (8.7) 2 (9.1)